Blood Component Therapies
The Institution will provide the required laboratory facilities and technical support in order for the Principal Investigator to conduct research in order to answer the following objectives: a. Evaluate clot structure and stability in clots formed from whole blood vs. red blood cell, plasma and platelet component therapy b. How do additive and storage solutions used to stabilise red blood cell and platelet component therapies alter clot structure and stability? c. How does cold or warm storage of blood products alt...
Buyer
MINISTRY OF DEFENCE
Value
£164,050
Published
28 Sept 2023
Closes
31 Aug 2023
Procurement details
Source
Contracts Finder
Region
United Kingdom
Procurement method
Direct
Category
Services
Contract starts
31 Aug 2023
Contract ends
31 Aug 2024
CPV classifications
73000000
Research and development services and related consultancy services
Lots
Lot default Blood Component Therapies
£164,050
The Institution will provide the required laboratory facilities and technical support in order for the Principal Investigator to conduct research in order to answer the following objectives: a. Evaluate clot structure and stability in clots formed from whole blood vs. red blood cell, plasma and platelet component therapy b. How do additive and storage soluti...
Documents
Unlock document linkAwarded contract notice on Contracts Finder
28 Sept 2023
Awarded contract notice on Contracts Finder
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.